The Union runs fee-based courses which help develop clinical expertise, management skills and the ability to discover solutions through research and advocacy.
Upcoming courses focus on the clinical and programmatic aspects of tuberculosis (TB), multidrug-resistant TB, TB-HIV and lung health. These courses contribute to implementation of public health programmes that provide quality diagnosis, treatment and care for patients with TB and build capacity of health professionals to record, report, monitor and evaluate services that are provided and ensure continuous quality assurance and strengthening in consultation with patients and communities.
Laboratory strengthening strategies to advance drug susceptibility testing for BPaL regimens in TB treatment
An article in a forthcoming issue of PHA assesses efforts to strengthen drug susceptibility testing in seven countries to support BPaL rollout, highlighting variable capacity and the need for ongoing training and infrastructure.
Financing the future of TB control: from dependence to resilience
An Editorial in a forthcoming issue of PHA highlights how cuts in donor funding for TB threaten progress but also present an opportunity for governments to invest in resilient, patient-centered health systems. The preprint is free to read.
Conflation of prediction and causality in the TB literature
A forthcoming IJTLD OPEN article addresses the frequent conflation of prediction and causal inference in observational TB studies, and outlines practical recommendations to enhance research precision and transparency.
The Union provides educational support to develop clinical expertise, management skills and the ability to discover solutions through research and advocacy. As well as our established series of in-person courses, The Union also offers tailored, custom courses and a series of online open access courses.